News
Imunon Inc (IMNN) progresses with pivotal Phase 3 trials while navigating financial hurdles and seeking strategic ...
That’s it for 2025’s Q1 clinical trials round-up. If you have a study that could fit the bill for our next column, please ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback